about
Electronic cigarettes. A position statement of the forum of international respiratory societiesSafety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections.Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden settingWithin-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic reviewClinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samplesHigh prevalence of smoking among patients with suspected tuberculosis in South Africa.Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?Diagnostic accuracy of induced sputum LAM ELISA for tuberculosis diagnosis in sputum-scarce patients.Feasibility and diagnostic utility of antigen-specific interferon-gamma responses for rapid immunodiagnosis of tuberculosis using induced sputum.Incidence of occupational latent tuberculosis infection in South African healthcare workers.The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics.Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden.Development of a simple reliable radiographic scoring system to aid the diagnosis of pulmonary tuberculosisSpontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature.Novel tests for diagnosing tuberculous pleural effusion: what works and what does not?Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?Impact of correcting the lymphocyte count to improve the sensitivity of TB antigen-specific peripheral blood-based quantitative T cell assays (T-SPOT.(®)TB and QFT-GIT).Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients.Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.Assessment of previous tuberculosis status using questionnaires, chest X-rays and computed tomography scans.Comparison of same day versus delayed enumeration of TB-specific T cell responses.Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.Electronic cigarettes: the potential risks outweigh the benefits.Utility of quantitative T-cell responses versus unstimulated interferon-{gamma} for the diagnosis of pleural tuberculosis.Tuberculosis, chronic obstructive pulmonary disease and inhaled corticosteroids: a complex web.E-cigarette vapour enhances pneumococcal adherence to airway epithelial cells.Five-year follow-up of participants diagnosed with chronic airflow obstruction in a South African Burden of Obstructive Lung Disease (BOLD) survey.Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis.Obstructive pulmonary disease in patients with previous tuberculosis: Pathophysiology of a community-based cohort.The Intention to Test for Latent Tuberculosis Should Be a Targeted Intention to Trust and Treat the Result.Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosisQuestionnaires for Lung Health in Africa across the Life CourseSmoking and tuberculous infection: chasing associations with imperfect exposure and outcome measures [Editorial]Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-weekChallenges for dedicated smoking cessation services in developing countriesSeeing the Wood for the Trees: Household Air Pollution and Lung DiseaseManagement of chronic obstructive pulmonary disease-A position statement of the South African Thoracic Society: 2019 updateA Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa
P50
Q28243586-7B72DE86-73A3-4D38-86EA-BE1990B07996Q33416170-7AA9F904-6CAB-4F5D-B1F2-2126D116A2E3Q33416753-D8C8AB71-DCCB-4CB2-9D5B-3CA351BC5BE2Q33521202-F1252029-0D8C-4A6F-B6F5-922DB15372F2Q33547441-BCDD2CAA-B39C-476F-8BC3-DDFB5FA6E3BEQ33754142-BCFFC6D0-235E-4D8A-91BA-B2F28A9958ACQ33777072-B7BCC7ED-1250-48FA-86C7-B22DEB7000FBQ33777355-B3B6E563-6FD2-406A-A4F5-C67938F5D3DEQ33815988-AF900B2C-4202-4177-B204-B320AA22524CQ33924856-CBADE9E7-8B09-4FFA-93E2-9994726B4CA8Q34039460-7BBE145F-20A5-4F91-95BF-1865897FAC2DQ34116991-9C960AC4-35E1-4C1B-906C-535D07F1C5ACQ34562819-A8A03410-1A70-4A40-B32B-23EFD9877A06Q34760591-E25BE6F5-1001-49D2-AAF7-ACC96A6B6E92Q37151586-9C64A3CB-7528-4172-8728-4BE73570B78FQ38410826-F312704A-1630-4318-8424-BFBC1566B491Q38427154-FEAE4423-5BE3-4C92-BEF9-A9E612B37EDBQ38563023-CAAC9E21-436A-43C9-882F-1FEFF971FE06Q39433439-75129BFD-05B9-4ACA-9A5C-82174EBEAA98Q40263239-E5C5774E-20B6-4C81-89EC-20FB95B06332Q40382721-54484544-B291-425D-AFFC-F4DDF999B65EQ41091578-003B1BFD-296D-41CE-8C4D-2BBBD81ADE2BQ46221029-0B0A70B0-D811-4156-940E-6BC76BBBB443Q46634611-C75F65C3-5A5F-4459-9415-41B3469A7C3DQ46643740-73155C35-F9A8-489E-9583-9669F59E47F0Q47961867-99CB910F-56C5-485C-BF60-8F832A466EB8Q49348112-88F7A1DE-7E22-4F3B-8553-92AF2FD6A0B2Q50043410-0B22BD7F-1C7B-465A-99B3-2A646E97BFEEQ50077158-F63283F5-0FA1-49E5-9DD6-63D8DB682874Q51066059-2CB41B8B-184C-425A-8722-F0D25B717FECQ53731095-2985D2CE-7419-47E5-B256-22A65B762B55Q53764017-765C0D69-2CEB-4985-A70B-A5C0DD7367B0Q56401830-AA646F2C-8488-4DDD-99DE-2D4D5C020D7FQ56911031-B6A3DE1A-3610-4EA0-9C3D-4F6CF5B0CD02Q59200631-5E5C627C-6FB1-4275-BDF7-C87F85EC94FCQ60306442-5151D3E5-74BA-4B6C-B6A1-55E49173589EQ91561713-3B1B2AD1-7ED5-49B1-85AF-AC8AE75EB899Q91718189-C7E18027-FC18-4B2D-B927-67F764A6625CQ92424726-37C1C4E8-0EC6-4F88-95A2-2B695A6FE654Q92460843-C4A1C963-9384-4263-A48C-B1110EF005F3
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Richard N van Zyl-Smit
@ast
Richard N van Zyl-Smit
@en
Richard N van Zyl-Smit
@es
Richard N van Zyl-Smit
@nl
Richard N van Zyl-Smit
@sl
type
label
Richard N van Zyl-Smit
@ast
Richard N van Zyl-Smit
@en
Richard N van Zyl-Smit
@es
Richard N van Zyl-Smit
@nl
Richard N van Zyl-Smit
@sl
prefLabel
Richard N van Zyl-Smit
@ast
Richard N van Zyl-Smit
@en
Richard N van Zyl-Smit
@es
Richard N van Zyl-Smit
@nl
Richard N van Zyl-Smit
@sl
P106
P1153
6603972670
P21
P31
P496
0000-0002-4115-5362